A prospective study on safety and efficacy in alleviating the symptoms of hemorrhoids and anal fissures

Frezyderm Rectanal Aid Ointment: A prospective study on safety and efficacy in alleviating the symptoms of hemorrhoids and anal fissures - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2025/03/083022

Enrollment

Registered

2025-03-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K60- Fissure and fistula of anal and rectal regions Health Condition 2: K64- Hemorrhoids and perianal venous thrombosis

Interventions

Intervention1: FREZYDERM RECTANAL AID OINTMENT: Is a gentle Ointment designed to provide relief of the symptoms of hemorrhoids and anal fissures. It moisturizes the rectal area and relieves intoleranc

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects suffering from hemorrhoids (grade I and II) and anal fissures 2.Both male and female 3.Both children and adults 4.Pregnant and breast-feeding females

Exclusion criteria

Exclusion criteria: 1.Subjects suffering from anal fistula 2.Grade III and IV hemorrhoids 3.Colorectal cancer or colorectal adenomas diagnosed 4.Rectal prolapse identified subjects 5.Subjects having peri-anal abscess

Design outcomes

Primary

Measure	Time frame
Primary Objective: The primary objective of this study is to assess the safety of the Frezyderm Rectanal Aid Ointment.Timepoint: The follow-up of the subjects will be conducted on day 7, day 15 and day 30.	—

Secondary

Measure	Time frame
Secondary Objective: The secondary objective of this study is to determine the efficacy of the Frezyderm Rectanal Aid Ointment. Timepoint: The follow-up of the subjects will be conducted on day 7, day 15 and day 30.	—

Countries

India

Contacts

Public ContactDr Saishyam M

Jana Raksha Multi-Speciality Hospital

msaisujay@gmail.com08892049546

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026